![John F. Kay](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John F. Kay
Keine laufenden Positionen mehr
Profil
John F.
Kay worked as President & CEO at Bio-Interfaces, Inc. from 1987 to 2001.
Prior to that, he was the Director of Research & Development at Calcitek, Inc. from 1981 to 1987.
He also served as the Chief Scientific Officer at IsoTis, Inc. from 2003 to 2007 and held the same position at IsoTis SA. Additionally, he was the Vice President of Research & Development at GenSci OrthoBiologics, Inc. from 2001 to 2003 and briefly served as the Vice President of Engineering at Artes Medical, Inc. in 2010.
Dr. Kay received his undergraduate, graduate, and doctorate degrees from Rensselaer Polytechnic Institute.
Ehemalige bekannte Positionen von John F. Kay
Unternehmen | Position | Ende |
---|---|---|
IsoTis, Inc.
![]() IsoTis, Inc. Medical SpecialtiesHealth Technology IsoTis, Inc. designs, manufactures and sells bone graft substitutes and other devices. The company was founded on November 15, 2006 and is headquartered in Plainsboro, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2007 |
GenSci OrthoBiologics, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2003 |
Bio-Interfaces, Inc. | Präsident | 01.06.2001 |
Calcitek, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1987 |
IsoTis SA
![]() IsoTis SA BiotechnologyHealth Technology IsoTis SA develops biomedical products. Its product include proprietary natural and synthetic bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Lausanne, Switzerland. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von John F. Kay
Rensselaer Polytechnic Institute | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
IsoTis, Inc.
![]() IsoTis, Inc. Medical SpecialtiesHealth Technology IsoTis, Inc. designs, manufactures and sells bone graft substitutes and other devices. The company was founded on November 15, 2006 and is headquartered in Plainsboro, NJ. | Health Technology |
IsoTis SA
![]() IsoTis SA BiotechnologyHealth Technology IsoTis SA develops biomedical products. Its product include proprietary natural and synthetic bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Lausanne, Switzerland. | Health Technology |
Artes Medical, Inc.
![]() Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | Finance |
Calcitek, Inc. | |
GenSci OrthoBiologics, Inc. | |
Bio-Interfaces, Inc. |